Remedy Pharmaceuticals

Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.

placeNew York City, New York, United States calendar_todayFounded 2004 groups6 employees language remedypharmaceuticals.com

Registered entities

Innovation

17 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 792 times.

YearFilings
20143
20152
20162
20173
20181
20192
20212
20221
20233
20244
202512
20262

Investor mix

6 investors on record; lead investors include Broadview Ventures, The Vertical Group.

Investor typeCountShare
Venture capital583%
Bank & private debt117%
Coming soon